Point State Capital LP is a global a hedge fund manager that focuses on macro investments. The company was founded in November 2010 by its current CEO Sean Cullinan and some of his former colleagues. According to the SEC 13F filings of Point State Capital LP for the quarter ended September 30, 2014, its primary holdings are Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), AbbVie Inc (NYSE:ABBV), and Cheniere Energy, Inc. (NYSEMKT:LNG).
The primary investment of Point State Capital LP for the third quarter of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) with a total of $558.47 million. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) is an international pharmaceutical company that specializes in generic and proprietary pharmaceutical products and ingredients. Point State Capital had the highest number of shares with a total of 10.39 million, followed by Highfields Capital Management with 6.37 million shares. (You can see complete list on hedge funds which hold positions on Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) at the end of the third quarter).
AbbVie Inc (NYSE:ABBV) was the second largest investment of the firm with total investment worth $437.16 million. AbbVie Inc (NYSE:ABBV) is a world renowned producer of pharmaceutical products with its headquarters in North Chicago, Illinois. Many hedge funds have recently purchased shares of the company due to its promising prospects, something that has given the company a lifetime high in trading. AbbVie Inc (NYSE:ABBV) has recently received a consensus rating of “buy” and an average price target of $66.62 from sixteen firms.
Cheniere Energy, Inc. (NYSEMKT:LNG) emerged as the third largest investment of Point State Capital LP, accounting for a total investment value of $384.88 million. Cheniere Energy, Inc. (NYSEMKT:LNG) is an energy company mainly focused on LNG-related business undertakings. The company also carries out a number of activities through its subsidiaries that include Frontera Pipeline, LLC, J&S Cheniere S.A., Cheniere Creole Trail Pipeline, L.P., just to mention a few. Cheniere Energy, Inc. (NYSEMKT:LNG) recently received a “buy” rating and an average price target of $35.91 from eleven firms that are currently covering it.
This article has been written by Victor Ochieng.
Related articles:
Teva Pharmaceutical Got Food and Drug Administration Approval
